ArticleMolecules (Basel, Switzerland)2026
Lipid Droplets as Cellular Sensors of Lipid Metabolic Reprogramming in Colon Cancer: Insights from Essential Amino Acid Supplementation Using Raman Spectroscopy and Imaging.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herein, we present a comprehensive single-cell investigation of the biochemical and metabolic responses of normal human colon fibroblasts (CCD-18Co) and colorectal adenocarcinoma cells (Caco-2) to supplementation with the amino acids leucine, threonine, and arginine, employing State-of-the-Art Raman spectroscopy and Raman imaging. This fully label-free and noninvasive methodology enabled high-spatial-resolution mapping of intracellular components, providing unprecedented insight into subcellular biochemical organization and metabolic remodeling associated with colorectal carcinogenesis. By synergistically integrating Raman spectroscopic data with advanced chemometric methods, we demonstrate robust, reproducible discrimination between normal and malignant colon cells, both in their native state and after amino acid treatment, based solely on their intrinsic vibrational fingerprints. Partial Least Squares Discriminant Analysis (PLS-DA) and one-way ANOVA revealed that perturbations in lipid metabolism and protein composition constitute key molecular determinants underlying the observed phenotypic divergence between control and amino acid-supplemented cells. Notably, detailed analysis of diagnostic Raman band intensity ratios (2845/3015, 2845/2930, 3015/2888, and 1444/1256) uncovered pronounced amino acid-driven alterations in metabolic pathways at the single-cell level. Raman imaging further enabled spatially resolved visualization of these biochemical shifts and changes in Raman band intensities, highlighting distinct lipid- and protein-rich subcellular domains that respond differentially to amino acid exposure in normal versus cancerous cells. Collectively, our findings establish Raman spectroscopy combined with chemometric analysis as a powerful and sensitive platform for decoding amino acid-induced metabolic reprogramming in colorectal cells. This approach deepens the mechanistic understanding of nutrient-cancer cell interactions and opens new avenues for the development of Raman-based strategies in cancer diagnostics and therapeutic response assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.